A case of reactive erythrocytosis with CD34/CD61 dual positive megakaryocytes
Corresponding Author
Mina Hur
Department of Laboratory Medicine, Konkuk University School of Medicine, Seoul, Korea
Correspondence
Mina Hur, Department of Laboratory Medicine, Konkuk University School of Medicine, Konkuk University Medical Center, 120-1, Neungdong-ro, Hwayang-dong, Gwangjin-gu, Seoul 05030, Korea.
Email: [email protected]
Search for more papers by this authorHanah Kim
Department of Laboratory Medicine, Konkuk University School of Medicine, Seoul, Korea
Search for more papers by this authorHee-Won Moon
Department of Laboratory Medicine, Konkuk University School of Medicine, Seoul, Korea
Search for more papers by this authorYeo-Min Yun
Department of Laboratory Medicine, Konkuk University School of Medicine, Seoul, Korea
Search for more papers by this authorMark Hong Lee
Department of Internal Medicine, Konkuk University School of Medicine, Seoul, Korea
Search for more papers by this authorCorresponding Author
Mina Hur
Department of Laboratory Medicine, Konkuk University School of Medicine, Seoul, Korea
Correspondence
Mina Hur, Department of Laboratory Medicine, Konkuk University School of Medicine, Konkuk University Medical Center, 120-1, Neungdong-ro, Hwayang-dong, Gwangjin-gu, Seoul 05030, Korea.
Email: [email protected]
Search for more papers by this authorHanah Kim
Department of Laboratory Medicine, Konkuk University School of Medicine, Seoul, Korea
Search for more papers by this authorHee-Won Moon
Department of Laboratory Medicine, Konkuk University School of Medicine, Seoul, Korea
Search for more papers by this authorYeo-Min Yun
Department of Laboratory Medicine, Konkuk University School of Medicine, Seoul, Korea
Search for more papers by this authorMark Hong Lee
Department of Internal Medicine, Konkuk University School of Medicine, Seoul, Korea
Search for more papers by this author
REFERENCES
- 1Debili N, Issaad C, Masse JM, et al. Expression of CD34 and platelet glycoproteins during human megakaryocytic differentiation. Blood. 1992; 80: 3022-3035.
- 2Ayala IA, Tomer A, Kellar KL. Flow cytometric analysis of megakaryocyte-associated antigens on CD34 cells and their progeny in liquid culture. Stem Cells. 1996; 14: 320-329.
- 3Sakurai K, Fujiwara T, Hasegawa S, et al. Inhibition of human primary megakaryocyte differentiation by anagrelide: a gene expression profiling analysis. Int J Hematol. 2016; 104: 190-199.
- 4Miyawaki K, Iwasaki H, Jiromaru T, et al. Identification of unipotent megakaryocyte progenitors in human hematopoiesis. Blood. 2017; 129: 3332-3343.
- 5Torlakovic G, Langholm R, Torlakovic E. CD34/QBEND10 immunostaining in the bone marrow trephine biopsy: a study of CD34-positive mononuclear cells and megakaryocytes. Arch Pathol Lab Med. 2002; 126: 823-828.
- 6Oertel J, Oertel B, Schleicher J, Huhn D. Immunotyping of blasts in human bone marrow. Ann Hematol. 1996; 72: 125-129.
- 7Monteferrario D, Bolar NA, Marneth AE, et al. A dominant-negative GFI1B mutation in the gray platelet syndrome. N Engl J Med. 2014; 370(245-25): 3.
- 8Marneth AE, van Heerde WL, Hebeda KM, et al. Platelet CD34 expression and alpha/delta-granule abnormalities in GFI1B- and RUNX1-related familial bleeding disorders. Blood. 2017; 129: 1733-1736.
- 9Machhi J, Bunyi-Teopengco E, Chang C, Wang G, Shidham VB, Kampalath B. CD34 expression in megakaryocytes favors myelodysplasia [abstract]. Mod Pathol. 2001; 14: 171A.
- 10Tang G, Wang SA, Menon M, Dresser K, Woda BA, Hao S. High-level CD34 expression on megakaryocytes independently predicts an adverse outcome in patients with myelodysplastic syndromes. Leuk Res. 2011; 35: 766-770.
- 11Chen Y, Chang H. CD34+ megakaryocytes and megakaryocytic fragments in myelodysplastic syndrome. Blood. 2017; 129: 2818.
- 12Duarte FB, DE Jesus Dos Santos TE, Barbosa MC, et al. Presence of CD34+ in megakaryocytes in association with p53 expression predicts unfavorable prognosis in low-risk myelodysplastic syndrome patients. Vivo. 2019; 33: 277-280.
- 13Thiele J, Kvasnicka HM, Orazi A, et al. Polycythaemia vera. In: SH Swerdlow, E Campo, NL Harris, et al., eds. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues revised 4th ed. Lyon, France: IARC Press; 2017: 39-43.